|Year : 2014 | Volume
| Issue : 1 | Page : 47-51
Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorrhage: Report of two cases and review of the literature
Taylor J Abel, Matthew A Howard, Arnold Menezes
Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
|Date of Web Publication||24-Jun-2014|
Taylor J Abel
Department of Neurosurgery, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, Iowa 52242
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Syringomyelia resulting from arachnoiditis secondary to aneurysmal subarachnoid hemorrhage (SAH) is an extremely rare clinical entity with few cases reported in the literature. The presentation, management, and pathogenesis of syringomyelia in this setting is poorly understood. We describe the presentation, radiology, management, and outcomes in two patients with syringomyelia resulting from arachnoiditis secondary to aneurysmal SAH and review the literature on this rare condition. Case number 1 was treated successfully with syrinx-subarachnoid shunt after extensive lysis of adhesions. Case number 2 was treated with syringoperitoneal shunt. Both patients had radiographic decreased syrinx size postoperatively. These patients add to the small literature on syringomyelia occurring secondary to SAH-associated arachnoiditis. The radiographic outcomes demonstrate that in the appropriately selected patient, syrinx-subarachnoid or syringoperitoneal shunting are viable options.
Keywords: Paraplegia, spinal arachnoiditis, subarachnoid hemorrhage, syringomyelia
|How to cite this article:|
Abel TJ, Howard MA, Menezes A. Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorrhage: Report of two cases and review of the literature. J Craniovert Jun Spine 2014;5:47-51
|How to cite this URL:|
Abel TJ, Howard MA, Menezes A. Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorrhage: Report of two cases and review of the literature. J Craniovert Jun Spine [serial online] 2014 [cited 2022 Jan 28];5:47-51. Available from: https://www.jcvjs.com/text.asp?2014/5/1/47/135227
| Introduction|| |
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating neurosurgical condition with significant morbidity for up to 50% of survivors.  An extremely rare complication of aneurysmal SAH is delayed spinal arachnoiditis that can occur months to years after the causative SAH. , Post-SAH spinal arachnoiditis was first described in 1943 by Nelson,  but several more cases have been reported since that time. ,,,, Even more rare than SAH-associated arachnoiditis is the development of syringomyelia secondary to arachnoiditis after aneurysmal SAH.  Due to the rarity of post-SAH syringomyelia, little is known about its presentation, pathogenesis, and management. In this report, we describe two cases of post-SAH spinal arachnoiditis with holochord syringomyelia and review the literature on this rare condition.
| Case reports|| |
History and physical
A 66-year-old retried lawyer presented for evaluation of known cervicothoracic syringohydromyelia. Eleven years prior to his presentation he suffered a SAH from a right fusiform vertebral artery aneurysm, which was clipped through a right suboccipital approach. After his SAH, he was hospitalized for 2 months and was in a coma for more than a month. Eight years after his SAH, he developed neck pain that lead him to obtain magnetic resonance imaging (MRI) demonstrating a cervicothoracic syrinx. He was seen by several neurosurgeons and eventually referred to the senior author (A.H.M.) University of Iowa Hospitals and Clinics.
On examination, he kept his neck flexed. Extraocular movements were full and his gag response was absent bilaterally. He had normal strength in his bilateral upper and lower extremities. Sensation was diminished to pain and light touch in the right neck, right trunk, and right upper extremity, but otherwise sensation was intact throughout. There were no pathologic reflexes. Imaging demonstrated a syringohydromyelia extending from the C1 level into the thoracic spine [Figure 1]]. Given stable imaging over several years and stable symptoms of neck pain and right upper extremity sensory change, a decision was made to follow him closely and monitor the syrinx.
|Figure 1: Sagittal T2-magnetic resonance imaging showing syringomyelia at presentation to UI neurosurgery. (a) One year after presentation. (b) Five months postoperatively. (c) The syrinx is decreased in size after syrinx-subarachnoid shunt|
Click here to view
One year later, the patient returned with difficulty ambulating, requiring the assistance of a walker over the previous 2 weeks. He had new bowel incontinence. Sensation was diminished in both lower extremities and right upper extremity. Strength was 4/5 in the right upper extremity and 3/5 in the right lower extremity. He also had 4/5 left hamstring strength, but otherwise all muscle groups on the left side were intact. Computerized tomographic myelogram via lumbar puncture was obtained and demonstrated cessation of contrast flow at the T9 level. Follow-up MRI demonstrated an increase in the syrinx from the levels of C1-C7 [Figure 1]b].
|Figure 2: (a) Intraoperative microscope photographs of Case number 1 syrinx-subarachnoid shunt placement. The arachnoid was densely opaque. (b) Opened to initiate lysis of adhesions. (c) The Subarachnoid space was satisfactorily opened. (d) To allow for placement of syrinxsubarachnoid shunt. (e) Subsequent arachnoid closure|
Click here to view
Given progression of symptoms, the patient underwent C5-C6 osteoplastic laminotomies. The dura was opened with care to preserve the underlying arachnoid membrane. The arachnoid was grossly abnormal and appeared white, opaque, and unusually vascular [Figure 2]a]. The dense "arachnoid" was opened and lysis of adhesions was performed [Figure 2]b]. The subarachnoid space was opened, allowing placement of a syrinx to subarachnoid shunt [Figure 2]c]. A midline myelotomy was performed to expose the syrinx cavity and the syrinx-subarachnoid shunt was then placed and secured [Figure 2]d]. The arachnoid membrane was then closed over the shunt tubing [Figure 2]e]. The patient tolerated the surgery well without complication.
By postoperative day 4, the patient had improved strength (grade 4+/5) in his right upper and lower extremities. Immediately after surgery, he had worsened proprioception in his right lower extremity, however this improved by postoperative day 6. Subjectively, the patient's sensation improved on the right side. He was able to ambulate with minimal assistance prior to discharge.
Five months following his operation, the patient returned to the hospital with new symptoms of right hemiparesis and hoarseness. On exam, he had decreased right facial sensation and decreased gag along with his right side hemiparesis. Brain and spinal MR were obtained and demonstrated an infarct in the right dorsolateral medulla. He was started on aspirin and plavix.
Magnetic resonance imaging of the neuraxis 2 years later demonstrated deflation of syringomyelia from 11 mm width to 3 mm [Figure 1]c]. The patient has not followed-up since.
History and physical
A 48-year-old woman with a 5-month history of progressive gait disturbance to the point of requiring a walker and eventually being wheelchair bound. Her past-medical history was significant for grade IV SAH from a ruptured right superior cerebellar artery aneurysm 8 years prior [Figure 3]a and b] treated at our institution. She had been treated via ventriculostomy and coil embolization of her aneurysm and did well. On examination, she had 5/5 strength in the upper extremities and 4/5 strength in her lower extremities. Sensation was decreased in the bilateral lower extremities. There was no change in bowel or bladder function. Neuraxis MR imaging was obtained and demonstrated holocord syringohydromyelia extending from C4 to the conus with arachnoid enhancement on contrast administration [Figure 4].
|Figure 3: Axial noncontrast computerized tomographic images demonstrating aneurysmal subarachnoid hemorrhage in Case number 2. There is massive hemorrhage in the basal cisterns (a), hemorrhage occluding the IVth ventricle (a), and substantial intraventricular hemorrhage (b)|
Click here to view
|Figure 4: Cervicothoracic syrinx demonstrated by sagittal T1 precontrast magnetic resonance (MR) (a) sagittal T1 postcontrast MR (b and d) Sagittal T2 MR. (e) Postcontrast images demonstrate signifi cant arachnoid enhancement secondary to arachnoiditis (b and d)|
Click here to view
Given progressive symptoms of weakness and sensory changes along with imaging findings of large syrinx, the patient underwent syrinx-peritoneal shunt placement. Osteoplastic laminectomies were performed at T7 and T8 to expose the dura. The arachnoid was thickened, white, and opaque with adhesions to the spinal cord and dorsal nerve roots [Figure 5]a]. Given the degree of arachnoiditis, the decision was made to perform a syrinx-peritoneal shunt rather than a syrinx-subarachnoid shunt. A midline myelotomy was performed at T7 to expose the syrinx and a catheter was set in place and secured to the pia-arachnoid [Figure 5]b]. The dura was closed around the proximal catheter in a standard fashion [Figure 5]c]. This was then tunneled to a right flank incision for insertion into the peritoneal cavity. The patient tolerated the surgery well without complications.
|Figure 5: (a) Intraoperative microscope photographs from Case number 2. The arachnoid was opaque. (b) A syringoperitoneal shunt was placed. (c) The dural closed around the proximal catheter|
Click here to view
By postoperative day 7, the patient had improved lower extremity strength to a grade of 4+/5. Six weeks after surgery, her symptoms remained stable. She continued to require a wheelchair for ambulation; however her weakness did not worsen further. MR imaging obtained 2 years after surgery demonstrated significant decreased in distension caused by syringohydromyelia.
| Discussion|| |
In this report, we document the presentation and management of two patients with delayed development of syringomyelia after aneurysmal SAH. This is an extremely rare complication of SAH with few cases reported in the literature.  The pathophysiology of syrinx formation after SAH is poorly understood, but is likely to result from arachnoiditis causing impaired cerebrospinal fluid dynamics (CSF) dynamics around the spinal cord. 
Spinal arachnoiditis is a chronic inflammation of the pia-arachnoid that occurs after meningitis, spinal trauma, SAH, and intrathecal injection. , The range of severity is broad for spinal arachnoiditis with mild cases characterized by faint arachnoid thickening and severe cases noted to have effacement of the subarachnoid space with the formation of arachnoid cysts.  Spinal arachnoiditis is associated with meningeal thickening, adhesions with cord deformity, meningeal contrast-enhancement, arachnoid cyst formation, and syrinx.  The presentation of spinal arachnoiditis is varied with many patients being completely asymptomatic, but patients with more severe pathology developing severe myelopathy or radiculopathy.  The mechanisms of syringomyelia in patients with spinal arachnoiditis are incompletely understood and recently reviewed by Klekamp.  Spinal arachnoiditis is thought to cause syringomyelia by two mechanisms: Obstruction of normal CSF flow and spinal cord tethering.  Arachnoiditis adhesions slow flow though the subarachnoid space, which increases subarachnoid pressure rostrally and intramedullary pressure caudally.  This pressure gradient leads to intramedullary edema and ultimately syringomyelia. 
The pathophysiologic mechanisms that mediate spinal arachnoiditis after SAH are incompletely understood. Many of the patients reported to develop spinal arachnoiditis after SAH had posterior fossa aneurysms (including the cases presented here), which may be due to blockage of the basal cisterns by blood.  This supports the idea of hematomyelia being the instigating stimulus for arachnoidopathy after SAH. After rupture of a cerebral aneurysm, a high concentration of blood products accumulates in the subarachnoid space leading to meningeal irritation and ultimately arachnoiditis. The presence of these blood products in the posthemorrhagic period initiates an inflammatory response and in turn induces a fibroproliferative state and this has potential to cause arachnoiditis anywhere in the neuraxis. , The initial phase of this response involves a rapid influx of inflammatory cells leading to local release cytokines.  The released cytokines signal a fibroproliferative response by attracting fibroblasts which ultimately leads to increased collagen synthesis.  This pathway may ultimately lead to obliteration of the subarachnoid space (with or without arachnoid cysts), adhesions, and spinal cord tethering that are characteristic of spinal arachnoiditis.
Spinal arachnoiditis resulting from aneurysmal SAH is rare with few cases reported in the literature. ,,,,,,,, In 1943, Nelson was the first to describe spinal arachnoiditis after SAH.  His patient was a 50-year-old man with thrombocytopenic purpora who became myelopathic years after suffering an intracranial hemorrhage. On autopsy, the patient was found to have diffused intracranial and spinal arachnoiditis with syringomyelia. In 1961, Lombardi et al. mentioned an additional three patients who developed spinal arachnoiditis after SAH, however there is no comment on the etiology of SAH in his patients.  In 2000, Kok et al. reviewed the literature on spinal arachnoiditis after SAH and found only 14 cases.  Of the cases reviewed, nearly all of them presented with symptoms of myelopathy and were found to have findings of arachnoiditis on neuroimaging when it was available. When a cerebral aneurysm rupture is the etiology of SAH precipitating spinal arachnoiditis, it is more commonly the result of aneurysm in the posterior fossa. In the review by Kok et al., in five of six cases in which the aneurysm location was known, the aneurysm originated from an artery in the posterior fossa.  More recently, Klekamp documented three of four patients with syringomyelia after SAH with posterior fossa aneurysms. 
Syringomyelia occurs in a small subset of patients who develop spinal arachnoiditis after aneurysmal SAH and therefore it is very rare. ,,, The characteristics of patients described in detail in the literature are summarized in [Table 1]. In 2012, Nakanishi et al. described two patients who presented with myelopathy and were found to have syringomyelia on spinal MR imaging.  The first patient developed myelopathy 20 months after rupture of a left MCA aneurysm and was found to have a C2-T10 syrinx, which was subsequently treated with a syrinx- subarachnoid shunt. The second patient presented 5 months after SAH and underwent IV th ventriculo-subarachnoid shunt for a medulla - C6 syrinx. Both patients demonstrated radiographic reduction in syrinx, but incomplete symptom relief. Also in 2012, Eneling et al. described two patients who presented with myelopathy after aneurysmal SAH who were found to have syringomyelia.  Both were treated with syrinx-periotoneal shunts and improved radiographically and symptomatically.
|Table 1: Summary of syringomyelia cases caused by arachnoiditis associated with aneurysmal SAH|
Click here to view
Arachnoiditis-associated syringomyelia may be treated with laminectomy with lysis of adhesions and duraplasty, syringosubarachnoid shunt, or syringoperitoneal shunt.  The most appropriate management is situation dependent and heavily debated. In Case number 1, lysis of adhesions was satisfactorily opened into the subarachnoid space to enable placement of syrinx-subarachnoid shunt. When distant adhesions are evident on preoperating MR imaging, local lysis of adhesions is unlikely to open the subarachnoid space well enough for effective syrinx to subarachnoid drainage. In these cases, syringoperitoneal shunt are necessary and can have satisfactory results as we have demonstrated in Case number 2.
| Conclusions|| |
Subarachnoid hemorrhage-associated arachnoiditis is an extremely rare cause of syringomyelia that can produce symptoms from months to years after aneurysmal rupture. The pathogenesis of arachnoiditis in this setting is not fully understood, but is associated with posterior fossa aneurysms suggesting that blood product hemolysis in the spinal subarachnoid space is an important factor. Successful treatment depends on restoration of CSF flow via lysis of adhesions with or without syringosubarachnoid shunt or syringoperitoneal shunting.
| References|| |
|1.||Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:2315-28. |
|2.||Augustijn P, Vanneste J, Davies G. Chronic spinal arachnoiditis following intracranial subarachnoid haemorrhage. Clin Neurol Neurosurg 1989;91:347-50. |
|3.||Kok AJ, Verhagen WI, Bartels RH, van Dijk R, Prick MJ. Spinal arachnoiditis following subarachnoid haemorrhage: Report of two cases and review of the literature. Acta Neurochir (Wien) 2000;142:795-8. |
|4.||Nelson J. Intramedullary cavitation resulting from adhesive spinal arachnoiditis. Arch Neuro Psychiatr 1943;50:1-7. |
|5.||Abhinav K, Bradley M, Aquilina K, Patel NK. Spinal arachnoiditis and cyst formation with subarachnoid haemorrhage. Br J Neurosurg 2012;26:574-5. |
|6.||Tumialán LM, Cawley CM, Barrow DL. Arachnoid cyst with associated arachnoiditis developing after subarachnoid hemorrhage. Case report. J Neurosurg 2005;103:1088-91. |
|7.||van Heerden J, McAuliffe W. Spinal arachnoiditis as a consequence of aneurysm-related subarachnoid haemorrhage. J Med Imaging Radiat Oncol 2013;57:61-4. |
|8.||Eneling J, Boström S, Rossitti S. Subarachnoid hemorrhage-associated arachnoiditis and syringomyelia. Clin Neuroradiol 2012;22:169-73. |
|9.||Klekamp J, Völkel K, Bartels CJ, Samii M. Disturbances of cerebrospinal fluid flow attributable to arachnoid scarring cause interstitial edema of the cat spinal cord. Neurosurgery 2001;48:174-85. |
|10.||Koyanagi I, Iwasaki Y, Hida K, Houkin K. Clinical features and pathomechanisms of syringomyelia associated with spinal arachnoiditis. Surg Neurol 2005;63:350-5. |
|11.||Sgouros S, Williams B. Management and outcome of posttraumatic syringomyelia. J Neurosurg 1996;85:197-205. |
|12.||Inoue Y, Nemoto Y, Ohata K, Daikokuya H, Hakuba A, Tashiro T, et al. Syringomyelia associated with adhesive spinal arachnoiditis: MRI. Neuroradiology 2001;43:325-30. |
|13.||Klekamp J. Treatment of syringomyelia related to nontraumatic arachnoid pathologies of the spinal canal. Neurosurgery 2013;72:376-89. |
|14.||Sajanti J, Majamaa K. Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1999;67:185-8. |
|15.||Sajanti J, Heikkinen E, Majamaa K. Transient increase in procollagen propeptides in the CSF after subarachnoid hemorrhage. Neurology 2000;55:359-63. |
|16.||Sajant J, Heikkinen E, Majamaa K. Rapid induction of meningeal collagen synthesis in the cerebral cisternal and ventricular compartments after subarachnoid hemorrhage. Acta Neurochir (Wien) 2001;143:821-6. |
|17.||Taguchi Y, Suzuki R, Okada M, Sekino H. Spinal arachnoid cyst developing after surgical treatment of a ruptured vertebral artery aneurysm: A possible complication of topical use of fibrin glue. Case report. J Neurosurg 1996;84:526-9. |
|18.||Nakanishi K, Uchiyama T, Nakano N, Fukawa N, Yamada K, Yabuuchi T, et al. Spinal syringomyelia following subarachnoid hemorrhage. J Clin Neurosci 2012;19:594-7. |
|19.||Lombardi G, Passerini A, Migliavacca F. Spinal arachnoiditis. Br J Radiol 1962;35:314-20. |
|20.||Lam S, Batzdorf U, Bergsneider M. Thecal shunt placement for treatment of obstructive primary syringomyelia. J Neurosurg Spine 2008;9:581-8. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]